ArticleFrontiers in veterinary science2026
Producer perceptions on the impacts of the withdrawal of zinc oxide on the health and welfare of weaned pigs.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Zinc oxide (ZnO) added to pig feed at prophylactic levels has been used to reduce post-weaning diarrhoea (PWD) and enhance performance. In response to concerns about antimicrobial resistance (AMR) and environmental contamination, supplementation with ZnO was prohibited in the European Union from June 2022, and in the United Kingdom from June 2024. Objective and method: We investigated the impacts of the withdrawal of ZnO on the health and welfare of weaned pigs as perceived by pig producers, and the management and husbandry factors associated with PWD in the United Kingdom. A mixed methods approach combined qualitative interviews with producers preparing to withdraw ZnO from their herds and a quantitative survey open to any producer. Findings were integrated using the transtheoretical model (TTM) of change as a guiding framework. Results: Eight qualitative interviews and 14 quantitative surveys with producers were completed. Responses to the qualitative interviews were all from indoor, breeder-finisher herds while the quantitative survey included indoor and outdoor production systems and a mix of breeder-finisher herds and nursery units. In the qualitative interviews, producers described ZnO as affordable and effective. Concerns were expressed that its withdrawal risked triggering a sectoral increase in antimicrobial usage, jeopardising reductions achieved to date. The quantitative survey revealed that almost all respondents (12/14, 85%) had experienced PWD in their piglets in the last year. At the time of responding, 57% of respondents (8/14) reported weaner pigs were not fed a diet containing ZnO during the post-weaning period whereas 36% (5/14) were still feeding a diet containing ZnO. Following the withdrawal of ZnO in June 2024, most respondents (8/14, 57%) anticipated supplementing weaner diets with an alternative to ZnO before and after weaning. Conclusion: While recognising the limitations of a small sample size, the study contributes to our understanding of producer perceptions as they prepared for the withdrawal of ZnO. Producer concerns that PWD would be less effectively controlled in their herds and risked triggering an increase in antimicrobial usage were highlighted. Further work is required to better understand the type and effectiveness of alternatives to ZnO on pig health and welfare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.